How the COG is Approaching the High-Risk Patient with ALL: Incorporation of Immunotherapy into Frontline Treatment.

Authors :: Gupta S
Maude SL
O'Brien MM
Rau RE
McNeer JL
Source :: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2020 Sep; Vol. 20 Suppl 1, pp. S8-S11.
Publication Year :: 2020

Subjects :: Adolescent
Child
Humans
Risk Factors
Young Adult
Antineoplastic Agents, Immunological therapeutic use
Immunotherapy methods
Precursor Cell Lymphoblastic Leukemia-Lymphoma drug therapy

Full Text Access

Tools